Although all mice showed signs of myeloproliferative disease, ~ 40% of the M-KrasG12D mice also developed T-cell leukemia, as determined by presence of CD4 and CD8 double-positive T cells along with enlarged thymuses (data not shown). This evidence concerns the gene CD4 and myeloproliferative disorder.